The physiologic role of GIP to regulate prandial glucose and lipid metabolism coupled with numerous preclinical studies commend GIPR antagonism as the appropriate mechanism to treat obesity. This evidence concerns the gene GIPR and obesity due to melanocortin 4 receptor deficiency.